Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical BTWT1, Btvita, and LeishG1 versus zinc oxide for post-procedure skin wound healing
IRCT20240304061158N2Phase 3Completed
- Sponsor
- Behpad Teb Iranian
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of zinc oxide in cutaneous wound (3 arms), sponsored by Behpad Teb Iranian. Primary endpoints: Pain intensity and duration, Exudation intensity and duration and 3 more. Started Jan 2024; status: completed.
02
Drugs
zinc oxide
03
Conditions
cutaneous wound
Beyond the preview
Go deeper on IRCT20240304061158N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240304061158N2.